BioSyent (CVE:RX) Hits New 12-Month High – What’s Next?

BioSyent Inc. (CVE:RX) shares hit a new 52-week high on Monday . The company traded as high as C$11.74 and last traded at C$11.74, with a volume of 4577 shares traded. The stock had previously closed at C$11.25.

BioSyent Stock Down 0.1 %

The stock has a market cap of C$133.40 million, a price-to-earnings ratio of 19.20 and a beta of 0.93. The firm’s 50 day moving average is C$11.08 and its two-hundred day moving average is C$10.32. The company has a current ratio of 6.13, a quick ratio of 6.91 and a debt-to-equity ratio of 3.19.

BioSyent (CVE:RX) last posted its quarterly earnings data on Monday, August 26th. The company reported C$0.13 EPS for the quarter, meeting analysts’ consensus estimates of C$0.13. BioSyent had a net margin of 21.14% and a return on equity of 20.88%. The company had revenue of C$8.95 million during the quarter, compared to the consensus estimate of C$8.80 million. On average, sell-side analysts predict that BioSyent Inc. will post 0.6944444 EPS for the current year.

Insider Buying and Selling at BioSyent

In other BioSyent news, Director Seyed Ahmad Ashrafi sold 2,320 shares of the business’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of C$10.95, for a total transaction of C$25,404.00. Also, insider FAX Capital Corp. sold 230,800 shares of the firm’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of C$11.12, for a total value of C$2,566,496.00. Over the last 90 days, insiders sold 234,357 shares of company stock valued at $2,605,854. Company insiders own 33.65% of the company’s stock.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.